SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 14, 2011

SYNOVIS LIFE TECHNOLOGIES, INC.

(Exact name of Registrant as specified in its charter)

State of Incorporation: Minnesota

Commission File No.: 0-13907

I.R.S. Employer Identification No.: 41-1526554

Address of principal executive offices:

2575 University Ave. W.

St. Paul, Minnesota 55114

Telephone Number: (651) 796-7300

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition

On December 14, 2011, Synovis Life Technologies, Inc. (Synovis) issued a press release announcing its earnings for the three and twelve months ended October 31, 2011. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Synovis will also publish the press release, including the supplemental information contained therein, on its website at www.synovislife.com.

The information contained in this report shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any filings made by Synovis under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as may be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(c)

Exhibits.

(99.1)

Synovis Life Technologies, Inc. News Release dated December 14, 2011.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	SYNOVIS LIFE TECHNOLOGIES, INC.

Dated: December 14, 2011	By:	/s/ Brett Reynolds
	Brett Reynolds
	Vice-President of Finance, Chief
	Financial Officer and Corporate Secretary

EXHIBIT INDEX

Exhibit No.	Description	Method Of Filing

(99.1)	Synovis Life Technologies, Inc. News Release dated December 14, 2011.	Filed herewith electronically.

SYNOVIS LIFE TECHNOLOGIES INC 8-K